SAROCCHI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 1.205
Totale 1.205
Nazione #
IT - Italia 1.205
Totale 1.205
Città #
Genova 684
Rapallo 243
Genoa 211
Vado Ligure 58
Bordighera 9
Totale 1.205
Nome #
Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. 137
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 121
Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational18F-FDG PET/CT observation 116
Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely 105
IL METABOLISMO CARDIACO ESPLORABILE IN VIVO CON FDG-PET È UN POTENZIALE MARCATORE DI CARDIOTOSSICITÀ DA ANTRACICLINE STUDIO SPERIMENTALE E CLINICO IN MODELLO MURINO E IN PAZIENTI CON LINFOMA DI HODGKIN 99
Arterial hypertension in cancer: The elephant in the room 95
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction 94
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline 93
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 76
Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program 55
Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer 53
Cancer Patient With Unusual Dyspnea in the COVID-19 Era 48
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 45
Bmi and acute kidney injury post transcatheter aortic valve replacement: Unveiling the obesity paradox 40
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 28
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement 26
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 16
Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents? 9
Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study 6
Totale 1.262
Categoria #
all - tutte 5.671
article - articoli 5.140
book - libri 0
conference - conferenze 254
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020306 0 0 0 30 29 43 54 32 36 43 31 8
2020/2021140 8 16 5 16 7 9 5 15 7 18 21 13
2021/2022171 4 4 10 16 4 13 19 36 17 14 6 28
2022/2023281 23 29 2 37 46 41 2 14 47 0 38 2
2023/2024172 16 13 4 23 12 33 7 14 2 8 15 25
2024/202576 31 22 14 9 0 0 0 0 0 0 0 0
Totale 1.262